Friday, 24 August 2012
Aquapharm recently announced a significant discovery in the development of next-generation antibiotics. It has discovered a novel antibiotic compound thought to be effective against a broad spectrum of Multi-Drug Resistant Gram-Positive bacteria
Thursday, 09 August 2012
Scottish biotechnology company Aquapharm Biodiscovery has discovered a novel antibiotic compound with potent activity against a broad spectrum of multi-drug-resistant Gram-positive bacteria.
Wednesday, 18 July 2012
In a pioneering collaboration the leading Scottish biotechnology company Aquapharm and German industrial biotechnology firm c-LEcta are set to fast-track the discovery and commercialisation of a new wave of bio-catalysts.
Monday, 14 May 2012
Scottish biotechnology firm Aquapharm has joined forces with the Medical Research Council’s Human Nutrition Research unit (MRC HNR) in Cambridge to evaluate the potential of a new approach to digestive health, called EndoSeaRch™.
Friday, 09 March 2012
Aquapharm has joined forces with the Australian Institute of Marine Science (AIMS) in a bid to discover innovative and high-value products from micro-organisms. The company is to to be given exclusive commercial access to a selection of Australian marine microbes in the AIMS Bioresources Library.